<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016194</url>
  </required_header>
  <id_info>
    <org_study_id>3840</org_study_id>
    <nct_id>NCT04016194</nct_id>
  </id_info>
  <brief_title>Prediction of Survival in Children With Cystic Fibrosis Using the Multiple-breath Washout</brief_title>
  <official_title>Multiple-breath Washout for Lung Function Testing in Children With Cystic Fibrosis: Predictive for Survival?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lindenhofspital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective cohort study using routinely collected annual data on lung clearance index
      (LCI) in combination with clinical data to predict survival in patients with Cystic Fibrosis.
      The primary study endpoint is the association of LCI with the compound outcome survival or
      lung transplantation in patients with CF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective analysis of longitudinal data collected during clinically routine from
      approximately 200 patients with CF aged 3 years or more between 01.01.1980 and 31.12.2005.
      The overall aim of this project is to retrospectively assess whether LCI measured for
      clinical purposes during school age is predictive for survival or lung transplantation in
      adulthood. For this, the investigators will assess in a systematic way clinically measured
      LCI and relate them with the compound outcome survival or lung transplantation
      retrospectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 1990</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung clearance index (LCI)</measure>
    <time_frame>Lung function is collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Lung function outcome derived by MBW and the compound Outcomes mortality or lung transplantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional residual capacity (FRC)</measure>
    <time_frame>Lung function is collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Lung function outcome derived by MBW</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expired Volume in 1 second (FEV1)</measure>
    <time_frame>Lung function is collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Lung function outcome derived by Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>Characteristics are collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Anthropometric characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body length</measure>
    <time_frame>Characteristics are collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Anthropometric characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gender</measure>
    <time_frame>Characteristics are collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Anthropometric characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Pseudomonas aeruginosa infection</measure>
    <time_frame>Characteristics are collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Clinical characteristics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Staphylococcus aureus infection</measure>
    <time_frame>Characteristics are collected quarterly until outcome (death or lung transplantation) or end of Study (12/2005) is reached</time_frame>
    <description>Clinical characteristics</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Death</condition>
  <condition>Lung Transplantation</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lung function testing</intervention_name>
    <description>Multiple-breath washout (MBW) is a safe, easy and sensitive lung function test using inert gases such as Nitrogen (N2) to assess efficiency of ventilation distribution. The latter can be estimated by the lung clearance index (LCI), an established study end-point in patients with CF</description>
    <other_name>Multiple-breath washout, MBW</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Non-Probability sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients treated at the Children`s Hospital Bern

          -  Confirmed CF Diagnosis

          -  Age &gt;= 3 years

        Exclusion Criteria:

          -  Uncertain diagnosis of CF according to current standards

          -  Existing written or otherwise documented refusal to participate in research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Singer</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Inselspital, Berne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Children's Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lindenhof Spital, Quartier Bleu</name>
      <address>
        <city>Bern</city>
        <zip>3012</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>July 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2019</study_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multiple-breath washout, MBW</keyword>
  <keyword>Lung clearance index, LCI</keyword>
  <keyword>Prediction</keyword>
  <keyword>Survival</keyword>
  <keyword>Cystic Fibrosis, CF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD will be shared with researchers involved in the data collection and analysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Until 12/2020</ipd_time_frame>
    <ipd_access_criteria>Researchers involved in data collection</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

